Foley Hoag LLP recently represented Alere Inc. (NYSE: ALR) in its acquisition of substantially all of the assets of US Diagnostics for $60 million in cash. US Diagnostics, based in Huntsville, Alabama, is a provider of drug testing devices and a distributor of Alere Toxicology products. Alere plans to use the transaction to provide access to an expanded customer base with additional opportunities for selling other Alere Toxicology solutions and other business synergies.
Headquartered in Waltham, Mass., Alere focuses on rapid diagnostics for infectious disease, cardiometabolic disease and toxicology.
Foley Hoag attorneys Mark Haddad, Erin Klein, James Schneider and Jeremy Arak represented Alere in the transaction.